Cover Image

PAPERBACK
$29.75



View/Hide Left Panel

Questions

Responses

Percentage

Count

How important do you feel precompetitive collaboration is to biomedical research?

Not at all important

5

1

Somewhat important

0

0

Important

5

1

Very important

23

5

Critical

68

15

Which research activity do you feel can benefit most from precompetitive collaboration?

Bioinformatics/software development

4

1

Data generation/collection efforts

35

8

Basic research

17

4

Translational/disease-focused research

35

8

Product-oriented research

9

2

What do you see as the biggest hurdle to precompetitive collaboration in biomedicine?

Individualist/competitive culture among academics

30

6

Proprietary culture of industry

25

5

Intellectual property issues

25

5

Academic promotion/tenure process

15

3

Publications

0

0

Patient privacy concerns

5

1

How relevant/applicable are industry collaborations, such as SEMATECH, to biomedical research?

Not at all important

0

0

Somewhat important

16

3

Important

16

3

Very important

42

8

Critical

26

5

How relevant/applicable are prizes, such as InnoCentive offers, to biomedical research?

Not at all important

0

0

Somewhat important

42

8

Important

26

5

Very important

21

4

Critical

11

2



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement